US HB6133 | 2017-2018 | 115th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on June 19 2018 - 25% progression, died in committee
Action: 2018-06-19 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 19 2018 - 25% progression, died in committee
Action: 2018-06-19 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018
Title
Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018
Sponsors
Rep. Mark Meadows [R-NC] |
History
Date | Chamber | Action |
---|---|---|
2018-06-19 | House | Referred to the House Committee on Energy and Commerce. |
2018-06-19 | House | Introduced in House |
Same As/Similar To
HB6 (Related) 2018-10-24 - Became Public Law No: 115-271.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
Subjects
Administrative law and regulatory procedures
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Food and Drug Administration (FDA)
Government studies and investigations
Health
Health care costs and insurance
Health care coverage and access
Health promotion and preventive care
Prescription drugs
Public participation and lobbying
Retail and wholesale trades
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Food and Drug Administration (FDA)
Government studies and investigations
Health
Health care costs and insurance
Health care coverage and access
Health promotion and preventive care
Prescription drugs
Public participation and lobbying
Retail and wholesale trades
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/115th-congress/house-bill/6133/all-info |
Text | https://www.congress.gov/115/bills/hr6133/BILLS-115hr6133ih.pdf |